Exact Mass: 363.2621

Exact Mass Matches: 363.2621

Found 18 metabolites which its exact mass value is equals to given mass value 363.2621, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Aurachin D

Aurachin D

C25H33NO (363.2562)


   

MLS000736682

1H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol

C25H33NO (363.2562)


   

Talinolol

N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N-cyclohexylcarbamimidic acid

C20H33N3O3 (363.2522)


Talinolol belongs to the family of Alkyl Aryl Ethers. These are organic compounds containing the alkyl aryl ether functional group with formula R-O-R , where R is an alkyl group and R is an aryl group. C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

Callyspongamide A

Callyspongamide A

C25H33NO (363.2562)


   

Broussonetine S

Broussonetine S

C18H37NO6 (363.2621)


   

Talinolol

N-{4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl}-N-cyclohexylcarbamimidic acid

C20H33N3O3 (363.2522)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AB - Beta blocking agents, selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

2-dihexoxyphosphoryl-N,N-diethylacetamide

2-dihexoxyphosphoryl-N,N-diethylacetamide

C18H38NO4P (363.2538)


   

1-(1-butylpiperidin-4-yl)-2-methyl-2-phenyl-3H-inden-1-ol

1-(1-butylpiperidin-4-yl)-2-methyl-2-phenyl-3H-inden-1-ol

C25H33NO (363.2562)


   

1-Bromo(20,20,20-2H3)icosane

1-Bromo(20,20,20-2H3)icosane

C20H38BrD3 (363.258)


   

Lapyrium

Lapyrium

C21H35N2O3+ (363.2648)


   

1H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol

1H-5alpha-Androst-2-eno[3,2-b]indol-17beta-ol

C25H33NO (363.2562)


   

SPHP(18:1)

SPHP(m18:1)

C18H38NO4P (363.2538)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-His 14:1(9Z)

NA-His 14:1(9Z)

C20H33N3O3 (363.2522)


   

(14z)-n-(2-phenylethyl)heptadec-14-en-4,16-diynimidic acid

(14z)-n-(2-phenylethyl)heptadec-14-en-4,16-diynimidic acid

C25H33NO (363.2562)


   

n-(2-phenylethyl)heptadec-14-en-4,16-diynimidic acid

n-(2-phenylethyl)heptadec-14-en-4,16-diynimidic acid

C25H33NO (363.2562)


   

(5z)-5-[(5-undecyl-1h-pyrrol-2-yl)methylidene]-1'h-2,2'-bipyrrole

(5z)-5-[(5-undecyl-1h-pyrrol-2-yl)methylidene]-1'h-2,2'-bipyrrole

C24H33N3 (363.2674)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]tridecane-1,4,13-triol

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]tridecane-1,4,13-triol

C18H37NO6 (363.2621)


   

(4s,13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]tridecane-1,4,13-triol

(4s,13r)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]tridecane-1,4,13-triol

C18H37NO6 (363.2621)